SEC Form 4 · accession 0001104659-15-040498
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 7:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | M | 13,945 | $11.68 | A | 49,996 | D | |
| Common StockF1 | May 20, 2015 | S | 13,945 | $14.7904 | D | 36,051 | D | |
| Common Stock | May 21, 2015 | M | 11,901 | $11.68 | A | 47,952 | D | |
| Common Stock | May 21, 2015 | M | 1,664 | $10.77 | D | 49,616 | D | |
| Common StockF2 | May 21, 2015 | S | 13,565 | $14.757 | D | 36,051 | D | |
| Common Stock | May 22, 2015 | M | 1,942 | $10.77 | A | 37,993 | D | |
| Common StockF3 | May 22, 2015 | S | 1,942 | $14.755 | D | 36,051 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $11.68 | May 20, 2015 | M | 13,945 | D | — | Dec 18, 2015 | Common Stock | 13,945 | 11,901 | D |
| Stock Option (right to buy)F4 | $11.68 | May 21, 2015 | M | 11,901 | D | — | Dec 18, 2015 | Common Stock | 11,901 | 0 | D |
| Stock Option (right to buy)F4 | $10.77 | May 21, 2015 | M | 1,664 | D | — | Dec 15, 2017 | Common Stock | 1,664 | 49,442 | D |
| Stock Option (right to buy)F4 | $10.77 | May 22, 2015 | M | 1,942 | D | — | Dec 15, 2017 | Common Stock | 1,942 | 47,500 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.76 to $14.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.70 to $15.00, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.70 to $14.80, inclusive.
- F4Shares subject to the option are fully vested and immediately exercisable.